CervoMed Stock (NASDAQ: CRVO) stock price, news, charts, stock research, profile.
Open | $24.330 |
Close | $24.360 |
Volume / Avg. | 19.935K / 31.768K |
Day Range | 23.990 - 25.620 |
52 Wk Range | 4.280 - 26.379 |
Market Cap | $183.646M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 54 |
Short Interest | 0.97% |
Days to Cover | 2.7 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of CervoMed (NASDAQ: CRVO) through any online brokerage.
Other companies in CervoMed’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), Galectin Therapeutics (NASDAQ:GALT), Adverum Biotechnologies (NASDAQ:ADVM) and bluebird bio (NASDAQ:BLUE).
The latest price target for CervoMed (NASDAQ: CRVO) was reported by Canaccord Genuity on Monday, April 8, 2024. The analyst firm set a price target for 65.00 expecting CRVO to rise to within 12 months (a possible 192.13% upside). 2 analyst firms have reported ratings in the last year.
The stock price for CervoMed (NASDAQ: CRVO) is $22.25 last updated May 8, 2024 at 7:03 AM EDT.
There are no upcoming dividends for CervoMed.
CervoMed’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for CervoMed.
CervoMed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.